Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis
- PMID: 32655234
- PMCID: PMC7335726
- DOI: 10.1016/j.jceh.2019.11.002
Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis
Abstract
Background: Renal replacement therapy in the form of either dialysis or transplantation is the only option for end-stage renal disease (ESRD). Blood-borne infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV) are of special concern in these patients because of their high incidence. Although there are sufficient data from the developed world, there is scarcity of data from developing countries such as India.
Methods: All newly diagnosed ESRD patients initiated on hemodialysis after attending the Department of Nephrology, PGIMER, Chandigarh between January 2015 and October 2015 were included in the study. All the subjects were initially screened for HCV and HBV serology status and subsequent HCV and HBV status on follow-up at the end of 6 months and evaluated by standardized precoded questionnaires and biochemical examinations. Univariate and multivariate analyses were done to identify the risk factors for seroconversion.
Results: A total of 196 patients were recruited for the study after confirming seronegative status. At the end of 6 months, 61 patients lost to follow-up. Anti-HCV antibody had shown moderate association to HCV RNA testing at the end of 6 months by kappa test. Out of 135, 16.3% seroconverted to HCV RNA positive and 0.7% patient became hepatitis B surface antigen positive. Isolation of dialysis machine and nursing staff was associated with lower seroconversion.
Conclusion: In a real-life scenario, HCV seroconversion is observed in 15% of the patients initiated on hemodialysis. Isolation of both dialysis machine and personnel was associated with lower seroconversion.
Keywords: ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; CKD, Chronic Kidney Disease; DAA, Direct-Acting Antiviral Disease; ESRD, End-Stage Renal Disease; HBV,, Hepatitis B Virus; HBsAg, Hepatitis B Surface Antigen; HCV, Hepatitis C Virus; end-stage renal disease; hemodialysis; hepatitis.
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V.
Figures
Similar articles
-
Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon.Iran J Kidney Dis. 2016 Sep;10(5):304-309. Iran J Kidney Dis. 2016. PMID: 27721229
-
[Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].Mikrobiyol Bul. 2014 Jan;48(1):143-50. Mikrobiyol Bul. 2014. PMID: 24506725 Turkish.
-
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.J Hepatol. 2014 Feb;60(2):253-9. doi: 10.1016/j.jhep.2013.09.023. Epub 2013 Oct 2. J Hepatol. 2014. PMID: 24096049 Clinical Trial.
-
[Evaluation of viral hepatitis in solid organ transplantation].Acta Med Croatica. 2014 Apr;68(2):151-9. Acta Med Croatica. 2014. PMID: 26012153 Review. Croatian.
-
Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.Arab J Nephrol Transplant. 2011 Jan;4(1):35-47. doi: 10.4314/ajnt.v4i1.63154. Arab J Nephrol Transplant. 2011. PMID: 21469594 Review.
Cited by
-
The prevalence of HCV RNA positivity in anti-HCV antibodies-negative hemodialysis patients in Thrace Region. Multicentral study.Germs. 2021 Mar 15;11(1):52-58. doi: 10.18683/germs.2021.1240. eCollection 2021 Mar. Germs. 2021. PMID: 33898341 Free PMC article.
-
Laboratory Evaluation of Hepatitis C Virus Infection in Patients Undergoing Hemodialysis from North East India.J Clin Exp Hepatol. 2022 Mar-Apr;12(2):475-482. doi: 10.1016/j.jceh.2021.05.011. Epub 2021 Jun 16. J Clin Exp Hepatol. 2022. PMID: 35535106 Free PMC article.
-
An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease.Pathogens. 2021 Oct 26;10(11):1381. doi: 10.3390/pathogens10111381. Pathogens. 2021. PMID: 34832537 Free PMC article. Review.
-
Updated Evidence on the Epidemiology of Hepatitis C Virus in Hemodialysis.Pathogens. 2021 Sep 7;10(9):1149. doi: 10.3390/pathogens10091149. Pathogens. 2021. PMID: 34578181 Free PMC article. Review.
-
Hepatitis C Virus Seroprevalence and Genotypic Distribution Among Hemodialysis Patients at a Teaching and Training Hospital in Western Rajasthan, India.Cureus. 2024 Aug 19;16(8):e67175. doi: 10.7759/cureus.67175. eCollection 2024 Aug. Cureus. 2024. PMID: 39295718 Free PMC article.
References
-
- Modi G.K., Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int. 2006 Dec;70:2131–2133. - PubMed
-
- Agarwal S.K., Dash S.C., Irshad M., Raju S., Singh R., Pandey R.M. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant. 2005 Aug;20:1638–1642. - PubMed
LinkOut - more resources
Full Text Sources